Literature DB >> 11894132

Osteopenia in survivors of Wilms tumor.

Fahad Othman1, Chun-Yuan Guo, Colin Webber, Stephanie A Atkinson, Ronald D Barr.   

Abstract

Diminished bone mass (osteopenia) is recognized increasingly as a consequence of therapy in survivors of cancer in childhood. It has been reported in two small series of survivors of Wilms tumor. The objectives of this study were to explore, in a larger sample of such subjects, the prevalence of osteopenia and a possible relationship between osteopenia of the lumbar spine and abdominal irradiation. All survivors of Wilms tumor (n=49) in a single institution were considered eligible for study. Thirty-one agreed to participate; the non-participants were not notably different in their demographic characteristics and diseases/treatment experience. Information was obtained about prior treatment, and usual diet, sun exposure and physical activity. Bone mineral content was measured by dual energy X-ray absorptiometry, and biochemical markers of bone turnover, calciotropic hormones and minerals were assessed in a single blood sample. By Z-scores of whole body bone mineral content, 8 subjects were osteopenic. This was unrelated to milk intake or sun exposure and was not more common in the lumbar spine of those who had been irradiated (15/31 subjects). Physical activity correlated positively with bone mineral density Z-scores (p<0.005). Normal bone formation was reflected in normal blood levels of osteocalcin. C-telopeptide levels, reflecting bone resorption, were high but approximately correlated inversely with maturity. Low serum magnesium and parathyroid hormone levels were detected in a minority of subjects. Osteopenia is present in a large minority (27%) of survivors of Wilms tumor, and an imbalance of bone turnover (with excessive resorption) may be common. Irradiation does not appear to play a causal role. It is possible that a subtle renal tubular defect exists in these individuals; a prospect worthy of further exploration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11894132

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  Hypomagnesemia in the Cancer Patient.

Authors:  Biruh T Workeneh; Nupur N Uppal; Kenar D Jhaveri; Helbert Rondon-Berrios
Journal:  Kidney360       Date:  2020-11-11

Review 2.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

3.  S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor.

Authors:  Mei-Hong Li; Teresa Sanchez; Harold Yamase; Timothy Hla; Myat Lin Oo; Anna Pappalardo; Kevin R Lynch; Chen-Yong Lin; Fernando Ferrer
Journal:  Cancer Lett       Date:  2009-01-07       Impact factor: 8.679

4.  Characterization of a WiT49 cell line derived orthotopic model of Wilms tumor.

Authors:  Mei-Hong Li; Harold Yamase; Fernando Ferrer
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

5.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

6.  Bone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management.

Authors:  Min Jae Kang; Jung Sub Lim
Journal:  Korean J Pediatr       Date:  2013-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.